The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


News Update

Biotech Involved in COVID-19, Neurodegenerative Diseases Reports Q3/20 Results

News Update
  ()
ProMIS Neurosciences formed two new joint ventures, one for developing tests for the detection, diagnosis and monitoring of Alzheimer's disease, and the second for serological assays for antibodies to the SARS-CoV-2 virus. read more >

Individuals Succeed Using This Digital TherapyŚNow It's Moving to Insurers

Contributed Opinion
  ()
Independent financial analyst Matt Badiali profiles a digital therapeutics company that is changing diabetes treatment. read more >

Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook

  ()
Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue. read more >

Exact Sciences Shares Rise 29% as Firm Announces Q3 Earnings, a Capital Raise and Two Acquisitions

  ()
Exact Sciences Corp. shares reached a new 52-week high after the maker of cancer screening test Cologuard reported Q3/20 financial results that included a greater than 86% increase in year-over-year revenue. read more >

CareDx Shares Trade Up 15% After Announcing 57% YoY Increase in Q3 Revenue

  ()
CareDx shares established a new 52-week high after the company reported that preliminary revenue in Q3/20 increased 57% year-over-year to $53.0 million. read more >

American Renal Associates Agrees to Private Equity Firm's $853 Million Buyout Offer

  ()
Shares of American Renal Associates traded 67% higher and set a new 52-week high after the company reported that it has entered into a definitive agreement to be acquired by a Nautic Partners LLC affiliate for $11.50 per share in cash. read more >

Genetron Receives FDA Breakthrough Approval for Hepatocellular Carcinoma Detection Device

  ()
Genetron Holdings Ltd. shares traded 25% higher after the company reported it has received Breakthrough Device Designation from the FDA for its blood-based next-generation sequencing test for early hepatocellular carcinoma detection. read more >

Aptorum Shares Skyrocket Upon Launching Infectious Disease Liquid Biopsy Unit

  ()
Shares of Aptorum Group Ltd. traded nearly 300% higher after the company reported it launched an infectious disease liquid biopsy start-up subsidiary. read more >

Bringing Order to Information Chaos Is a Necessity in the Age of COVID-19

  ()
Leonovus, a data storage and security technology firm, positions its software to enable healthcare groups to organize massive amounts of COVID/public health data. read more >

Fluidigm Shares Climb 34% After FDA Authorizes Saliva-Based COVID-19 Test

  ()
Fluidigm Corp. shares reached a new 52-week high after the firm reported the FDA granted Emergency Use Authorization for saliva-based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19. read more >

Firm's Home Health Monitoring System Provides the 'Most Comprehensive Offering in the Telehealth Space'

  ()
As the Covid pandemic accelerates the adoption of telemedicine technology, Reliq Health Technologies' recent contracts represent exponential growth. read more >
News Update

Canadian Biotech Advances Antibodies, Diagnostics Programs in Q2/20

News Update
  ()
One highlight is ProMIS Neurosciences' development of a SARS CoV-2 antibody test. read more >

$18.5 Billion Merger Could Mean Big Gains for These Five Tiny Telemedicine Stocks

Contributed Opinion
  ()
Independent financial analyst Matt Badiali examines five small companies poised to profit as digital health becomes mainstream during the coronavirus pandemic. read more >

US Immunology Firm Lands Government Contract, Raises Cash

Research Report
  ()
These two CytoSorbents events are discussed in a Dawson James report. read more >
News Update

Tech Firm Explains Key Feature of its Contact Tracing Solution

News Update
  ()
Loop Insights' technology lacks the adoption challenges that app-based solutions face. read more >

Fulgent Genetics' Shares Reach New 52-Week High After Posting 105% Increase in Q2 Revenue

  ()
Shares of Fulgent Genetics traded 22% higher after the company reported it posted a record $17.1 million in Q2/20 revenue and completed a record 180,513 billable tests in the quarter. read more >
News Update

Mobile Health Tech Firm Joins with US Healthcare Group to Bring Care Platform to 50,000 Patients

News Update
  ()
Reliq Health Technologies reported it has entered into a new contract with Diversified Healthcare Partners to provide its iUGO Care platform to more than 50,000 patients in three U.S. states. read more >

Coverage Initiated on 'Emerging Colossus in Diagnostics and Life Science'

Research Report
  ()
Meridian Bioscience's business segments, revenue and growth as well as COVID-19's positive impact on them are reviewed in an H.C. Wainwright & Co. report. read more >

Biopharma's Therapeutic Jumps to Phase 2 Testing for COVID-19 'to Shut Down the Cytokine Storm'

Research Report
  ()
A development update on Sorrento Therapeutics' three coronavirus-related products is provided in a Dawson James report. read more >

Cheap Valuation and Fastest Revenue Growth in Telemedicine? Analyst Says Yes.

Contributed Opinion
  ()
In the time of Covid-19, Peter Epstein of Epstein Research breaks down the investment opportunity offered by CloudMD. read more >

Virtual Healthcare Tech Firm's Contract in Puerto Rico Is Its Largest by 400%

  ()
Reliq Health Technologies' agreement with digiiMED makes its platform available to more than 200,000 patients. read more >
News Update

Biotech Partners to Develop, Offer Alzheimer's Disease Tests

News Update
  ()
ProMIS Neurosciences and its collaborator make their relationship official with a joint venture agreement. read more >

Preclinical COVID-19 Vaccine Data 'Encouraging'

Research Report
  ()
Updates on Sorrento Therapeutics' two coronavirus-related products are provided in an H.C. Wainwright & Co. report. read more >

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX

  ()
Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. read more >
News Update

Biotech Makes 'Significant Progress' Creating Highly Accurate COVID-19 Antibody Test

News Update
  ()
ProMIS Neurosciences states that the current version of the ProMIS-BCNI assay achieves 99.9% sensitivity and 99.5% specificity for SARS CoV-2, the coronavirus causing COVID-19. read more >
Showing Results: 1 to 25 of 29 Next

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts